Clinical features and prognosis of severe legionnaires' disease requiring intensive care unit admission: a multicentric retrospective cohort study
- PMID: 40851006
- PMCID: PMC12376721
- DOI: 10.1186/s41479-025-00173-z
Clinical features and prognosis of severe legionnaires' disease requiring intensive care unit admission: a multicentric retrospective cohort study
Abstract
Introduction: Legionella is the second cause of community-acquired pneumonia in Intensive Care Unit (ICU) patients. The aim of this study was to describe the epidemiology and outcome in patients with Legionella pneumonia (LP) in French ICUs.
Methods: A multi-center, retrospective, observational study in 12 French ICUs was performed between January 2014 and December 2019.
Results: LP was diagnosed in 162 patients during the study period. Invasive mechanical ventilation was required in 95 patients (58%), 73 (45%) of whom had acute respiratory distress syndrome (ARDS). Most of these patients were treated with a combination of antibiotics (128, patients; 79%). The most common combination consisted in a fluoroquinolone and a macrolide (118 patients). Median length of stay in an ICU was 11 [5; 11] days. At 28 days, 19 (12%) out of the 162 patients had not survived. In multivariate analyses, age (Incidence risk Ratio: IRR, 1.07; 95% CI, 1.01; 1.14) and a high Sequential Organ Failure Assessment (SOFA) score in the first 48 h (IRR, 1.47; 95% CI, 1.09; 2) were significantly associated with mortality.
Conclusion: In this French multicentric cohort, the LP prognosis in ICUs was apparently more favorable than in the literature, possibly because of the timely and improved LP management in ICUs.
Keywords: Antibiotherapy; Intensive Care Unit; Legionella pneumophila; Septic shock.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Eligible patients were informed about the study by letter from each participating center. Their data were included in the study if they did not object. The study was approved by the Ethics Committee of the French Intensive Care Society (SRLF, Société de Réanimation de la Langue Française, CE 22–040). Consent for publication: All authors consent for publication. Competing interests: The authors declare no competing interests.
Figures
References
-
- Stout JE, Yu VL, Legionellosis. N Engl J Med. 1997;337(10):682–7. - PubMed
-
- Phin N, Parry-Ford F, Harrison T, Stagg HR, Zhang N, Kumar K, et al. Epidemiology and clinical management of legionnaires’ disease. Lancet Infect Dis. 2014;14(10):1011–21. - PubMed
-
- European Centre for Disease Prevention and Control. Legionnaires’ disease. In: ECDC. Annual Epidemiological Report for 2021. Stockholm: ECDC; 2023. Accessed: https://www.ecdc.europa.eu/sites/default/files/documents/legionnaires-di....
-
- Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance). Accessed: https://www.legislation.gov.uk/eudn/2018/945.
-
- Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71–9. - PubMed
LinkOut - more resources
Full Text Sources